{"disease":{"id":"squamous-cell-carcinoma-of-the-skin","name":"squamous cell carcinoma of the skin"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03621462","title":"Elucid Labs AIDA™ - Labelled Image Acquisition Protocol","phase":"NA","overall_status":"UNKNOWN","enrollment_count":4000,"lead_sponsor_name":"Elucid Labs Inc.","has_results":false},{"nct_id":"NCT07347392","title":"The Role of Radiotherapy for the Management of Non-melanoma Skin Cancer in Denmark.","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":2900,"lead_sponsor_name":"University of Aarhus","has_results":false},{"nct_id":"NCT07361666","title":"Impact of Preoperative High-Frequency Ultrasound Cutaneous Lesion Extent Assessment on Excision Margin Positivity in Head and Neck Skin Cancer, and the Relationship Between Preoperative Assessment Methods, Inadequate Excision Margins, and Tumor Recurrence","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":400,"lead_sponsor_name":"Państwowy Instytut Medyczny Ministerstwa Spraw Wewnętrznych i Administracji","has_results":false},{"nct_id":"NCT04892849","title":"Clinical Benefit and Biomarker Analysis of Combination of PD-1/PD-L1 Immune Checkpoint Inhibitors and Radiotherapy","phase":"","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"University of Erlangen-Nürnberg Medical School","has_results":false},{"nct_id":"NCT05269381","title":"Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":132,"lead_sponsor_name":"Mayo Clinic","has_results":false},{"nct_id":"NCT05086692","title":"A Beta-only IL-2 ImmunoTherapY Study","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":115,"lead_sponsor_name":"Medicenna Therapeutics, Inc.","has_results":false},{"nct_id":"NCT05482880","title":"Decisional Conflicts, Health-related QoL and Satisfaction With Care in High-risk cSCC in the Head-neck Region","phase":"","overall_status":"COMPLETED","enrollment_count":78,"lead_sponsor_name":"Maastricht University Medical Center","has_results":false},{"nct_id":"NCT03325738","title":"Cetuximab for Unresectable Cutaneous Squamous Cell Carcinoma - A National Retrospective Study","phase":"","overall_status":"COMPLETED","enrollment_count":60,"lead_sponsor_name":"Centre Antoine Lacassagne","has_results":false},{"nct_id":"NCT03370861","title":"How Microbes and Metabolism May Predict Skin Cancer Immunotherapy Outcomes","phase":"","overall_status":"TERMINATED","enrollment_count":54,"lead_sponsor_name":"Washington University School of Medicine","has_results":false},{"nct_id":"NCT03894618","title":"SL-279252 (PD1-Fc-OX40L) in Subjects With Advanced Solid Tumors or Lymphomas","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":49,"lead_sponsor_name":"Shattuck Labs, Inc.","has_results":true},{"nct_id":"NCT05246228","title":"Immune System Modulation and Outcome in High-risk cSCC Treated With Surgery and Radiotherapy","phase":"","overall_status":"UNKNOWN","enrollment_count":42,"lead_sponsor_name":"Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia","has_results":false},{"nct_id":"NCT05144698","title":"RAPA-201 Therapy of Solid Tumors","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":37,"lead_sponsor_name":"Rapa Therapeutics LLC","has_results":false},{"nct_id":"NCT05574101","title":"A Study of Radiation Therapy and Cemiplimab for People With Skin Cancer","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":34,"lead_sponsor_name":"Memorial Sloan Kettering Cancer Center","has_results":false},{"nct_id":"NCT05886140","title":"Carrilizumab Combined With White Purple for Squamous Cell Carcinoma of Skin","phase":"NA","overall_status":"UNKNOWN","enrollment_count":24,"lead_sponsor_name":"Henan Cancer Hospital","has_results":false},{"nct_id":"NCT05490485","title":"Camrelizumab Combined With Cisplatin in the Treatment of Advanced Cutaneous Squamous Cell Carcinoma","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":20,"lead_sponsor_name":"Henan Cancer Hospital","has_results":false},{"nct_id":"NCT06046625","title":"Needs and Preferences of Patients With Head-neck Cutaneous SCC","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":15,"lead_sponsor_name":"Maastricht University Medical Center","has_results":false},{"nct_id":"NCT02324608","title":"Cetuximab Before Surgery in Treating Patients With Aggressive Locally Advanced Skin Cancer","phase":"NA","overall_status":"COMPLETED","enrollment_count":15,"lead_sponsor_name":"Rutgers, The State University of New Jersey","has_results":true},{"nct_id":"NCT04480645","title":"CivaDerm(TM) Surface Therapy Pilot Study","phase":"EARLY_PHASE1","overall_status":"COMPLETED","enrollment_count":10,"lead_sponsor_name":"CivaTech Oncology","has_results":false},{"nct_id":"NCT03737721","title":"The UNSCARRed Study: UNresctable Squamous Cell Carcinoma Treated With Avelumab and Radical Radiotherapy","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":8,"lead_sponsor_name":"AHS Cancer Control Alberta","has_results":false}],"total":19},"guidelines":[],"source":"Drug Landscape verified database"}